AI-generated summary
The authors retrospectively reviewed medical records of 72 patients with recalcitrant viral warts treated with pulsed dye laser (39 patients) or long pulsed Nd:YAG laser (33 patients). They report complete clearance in 5.1% of the pulsed dye laser group and 9.1% of the long pulsed Nd:YAG group, with at least 50% improvement in 51.3% and 66.7% respectively, and describe both as potentially safe alternatives.
- Participants
- 72
- Who or what was studied
- Patients with recalcitrant viral warts treated with laser therapy between January 2013 and February 2016
- Limits stated in the abstract
- The study was retrospective, and the abstract does not describe a control group or statistical comparison between the two laser groups.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 14 J/cm2, 300 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.